Genitourinary Syndrome of Menopause Clinical Trial
Official title:
Vaginal Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors - A Randomized, Blinded, Placebo-controlled Study
This project will be based on three studies over a period on three years. The first study is a dose response study that includes 30 breast cancer survivors. They will receive a total of 5 laser treatments with 4-6 weeks intervals The second study is a double-blind randomized controlled trial, that includes 60 breast cancer survivors. 30 of those will receive active intervention and 30 will receive placebo laser treatment and act as controls. Based on the results of the dose response study, a treatment consists of three to five laser treatments every 3 weeks. The third and last study is a one-year follow-up on study two. The conditions are evaluated before and after each treatment by questionnaires, vaginal fluid pH values, punch biopsies and vaginal and urine microbiome. The studies is conducted at the Department of Obstetrics and Gynaecology at Randers Regional Hospital in collaboration with Department of Obstetrics and Gynaecology and Department of Oncology at Aarhus University Hospital.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05812924 -
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
|
Phase 2 | |
Completed |
NCT04535323 -
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer
|
Phase 1 | |
Completed |
NCT03331328 -
MonaLisa Touch Randomized Double-Blind Placebo Controlled Study
|
N/A | |
Recruiting |
NCT04746456 -
Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
|
||
Withdrawn |
NCT04606550 -
MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study
|
N/A | |
Completed |
NCT04705883 -
Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors
|
Phase 4 | |
Recruiting |
NCT05953090 -
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
|
N/A | |
Active, not recruiting |
NCT04619485 -
Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy
|
N/A | |
Completed |
NCT04607798 -
Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy
|
N/A | |
Recruiting |
NCT06124820 -
RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections
|
N/A | |
Completed |
NCT05561972 -
The Ultrasonographic Assessment of Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause
|
N/A | |
Recruiting |
NCT05571527 -
Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause
|
N/A | |
Recruiting |
NCT04677491 -
Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders
|
Phase 4 | |
Not yet recruiting |
NCT06425978 -
Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit
|
Phase 4 | |
Recruiting |
NCT05672901 -
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
|
N/A | |
Recruiting |
NCT03782480 -
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
|
Phase 3 | |
Recruiting |
NCT06028009 -
PRP Injections for Genitourinary Syndrome of Menopause
|
N/A | |
Terminated |
NCT03857893 -
New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy
|
N/A | |
Completed |
NCT05782920 -
Management of Cancer Therapy Related Vulvovaginal Atrophy
|
N/A | |
Completed |
NCT05464654 -
Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause
|
N/A |